Jeannie Fontana

Jeannie Fontana, MD-PhD, a trailblazer in healthcare and ALS research funding, joins Robin Carhart-Harris, the founder of the Center for Psychedelic Research. They explore the TREAT Initiative in California, aiming to secure vital funding for psychedelic treatments in mental health. The conversation covers the legal landscape for psychedelics, the importance of safe therapeutic practices, and ongoing advocacy efforts. They also delve into the neuroscience behind psychedelics, discussing their potential for treating conditions like PTSD and their impact on brain function.

Jeannie Fontana and Robin Carhart-Harris discuss the Treat California initiative, the therapeutic potential of psychedelics, and the future applications of psychedelic medicine. They emphasize the need for large-scale clinical trials, patient education, and accessibility. The chapter also explores the financial challenges of conducting well-run studies, the effects of psychedelic drugs on the brain, and the need for non-denominational dialogue.

Jeannie Fontana, CEO of the TREAT California Initiative, talks about the potential of psychedelic research in treating mental illness and improving well-being. She also discusses her advocacy work for ALS patients and stem cell research funding. The podcast explores the impact of politicizing science and reflections on COVID-19, politics, and mental health. It delves into barriers and streamlining research on stem cells and perspectives on psychedelic medicine. The speaker discusses traditional societies vs. the American approach to psychedelics and the importance of integrating Western medicine and Eastern philosophies for mental health.